Patent litigators and their clients already have new fodder for strategic consideration in 2015, in the form of the Supreme Court decision in Teva v. Sandoz on January 20 and the Federal Circuit decision in In re Cuozzo Speed Techs on February 4-the latter case providing a launch point for a spirited discussion on the pros and cons of taking patent disputes into inter partes review proceedings before the U.S. Patent Trial and Appeal Board. Meanwhile, the patent-killing...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In